SCHEMBL8935286

SCHEMBL8935286

CN(Cc1ccc(OCc2ccccc2Cl)cc1)C(=O)C(N)CO

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.54
MAOA P21397 1/20 0.52
NR4A2 P43354 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.46
HTT P42858 2/20 0.46
LMNA P02545 2/20 0.46
SLC1A5 Q15758 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
MAPT P10636 3/20 0.45
TP53 P04637 2/20 0.45
GAA P10253 1/20 0.45
ADAM17 P78536 1/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8935297 0.88 MAOB (0.59) MAOBMAOANR4A2SMN1; SMN2HTT
SCHEMBL8935310 0.86 MAOB (0.55) MAOBSLC1A5
SCHEMBL8935348 0.84 MAOB (0.58) MAOBMAOAGAAALDH1A1MEN1
SCHEMBL8935296 0.81 ALOX5 (0.60) MAOBMAOA
SCHEMBL8935232 0.79 FFAR1 (0.51) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL9129282 0.78 MAOB (0.61) MAOBMAOANR4A2SMN1; SMN2HTT
SCHEMBL7398570 0.78 MAOB (0.61) MAOBMAOANR4A2SMN1; SMN2HTT
SCHEMBL7394825 0.77 MAOB (0.54) MAOBMAOANR4A2SMN1; SMN2HTT
SCHEMBL9130157 0.77 MAOB (0.54) MAOBMAOANR4A2SMN1; SMN2HTT
SCHEMBL8935251 0.76 MAOB (0.58) MAOBMAOANR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5502079-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS FARMITALIA CARLO ERBA S.R.L. (IT) 1996-03-26 US disclosed